Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease 2019 vaccine, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Spend time with your patients, discussing both the risks and benefits of a potential coronavirus disease (COVID) 2019 vaccine; talk with them about their fears; and perhaps most important, be patient and transparent, emphasized Maura Abbott, PhD, AOCNP, CPNP, RN, assistant professor of nursing at the Columbia University School of Nursing.
Transcript
What can be said to assuage the fears people have about a coronavirus vaccine?
I think many of these fears are very common about any sort of clinical trial, whether it be a COVID vaccine or even trials for new cancer therapies. I think people inherently have fears, because it's a clinical trial and something that's new. And so I think what we can say as health care providers to assuage our patients’ fears is just basically to spend the time answering their questions, provide as much transparent information as we have, as possible, about the process of development, about the potential side effects.
And I think, again, we just need to be patient with people, as they're able to state their fears and we're able to answer their questions and patiently work with them very transparently, and at the level that they understand. Don't talk above their heads. Tell them exactly what's going on.
Talking about risks and benefits is another really important part of this. As you mentioned, there are definitely people that are disproportionately affected, and persons of color, and I think that's something that we should discuss with our patients when applicable.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
AI's Role in Oncology: Supporting, Not Replacing, Health Care Providers
January 9th 2025In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial intelligence (AI) in cancer care.
Read More